Epicur’s new Buprenorphine ER is a long-acting Buprenorphine SR analgesic, specifically developed for research rats and mice.
Developed with input from laboratory animal veterinarians, scientists, research personnel, vivarium directors and distributors across North America and Europe.
Learn more about our new, longer-lasting buprenorphine for your lab or facility—get the brochure!
RACE-Approved CE Credit Hours: 1
Free to attend
Explore the importance of pain management in laboratory rodents, focusing on a new extended-release buprenorphine injectable. Attendees will learn how its low viscosity improves administration, reduces handler strain, and enhances animal comfort. The session will also cover best practices for administration and monitoring.
Buprenorphine ER is a long-acting buprenorphine analgesic designed for sustained pain relief in rats and mice with a single SC injection.
Labor-saving fewer interventions
Validated efficacy 72+ hours of action
Extended shelf life fewer reorders, reduced waste
Regulatory-driven enhanced pain mitigation
Compliant with GFI #256 available for office use in every state except ND
High protocol compliance reduced error margin & pharmaceutical waste, improved regulatory compliance
Optimized viscosity compatible with small-gauge needles (27-30G)
Compatible with most research protocols involving post-op and post-procedure pain.
|
FEATURE
|
Buprenorphine ER
|
Ethiqa XR
|
|---|---|---|
|
Duration
|
72-96 hours
|
|
|
Shelf Life
|
6 months (pending)
|
|
|
Labor Reduction
|
High
|
|
|
Indexing
|
